JW Lifescience Corporation (234080.KS)
KRW 11520.0
(-0.78%)
KRW 11520.0
(-0.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 37.5 Billion | 14.12 Billion | 30.16 Billion | 46.75 Billion | 24.27 Billion | 36.12 Billion |
| Net Income | 28.14 Billion | 14.96 Billion | 12.91 Billion | 17.3 Billion | 21.93 Billion | 15.82 Billion |
| Depreciation & Amortization | 15.5 Billion | 14.95 Billion | 13.24 Billion | 12.24 Billion | 11.62 Billion | 11.09 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.28 Billion | -22.38 Billion | -3.65 Billion | -1.59 Billion | -13.12 Billion | 7.27 Billion |
| Other non-cash items | -4.86 Billion | 6.59 Billion | 7.66 Billion | 18.8 Billion | 3.83 Billion | 1.93 Billion |
| Investing Cash Flow | 8.03 Billion | -28.24 Billion | -22.8 Billion | -37.56 Billion | -8.37 Billion | -10.38 Billion |
| Investments in PPE | -8.26 Billion | -8.29 Billion | -19.39 Billion | -16.23 Billion | -8.35 Billion | -10.56 Billion |
| Acquisitions | 3.69 Million | -12 Million | 1.7 Million | -19.7 Billion | -10 Million | - |
| Investment purchases | -21.2 Billion | -38.38 Billion | -655.9 Million | -1.7 Billion | -10 Million | - |
| Sales/Maturities of investments | 38.23 Billion | 13.63 Billion | 9.39 Billion | -297.76 Million | 10 Million | 104.47 Million |
| Other Investing Activities | -736.19 Million | 4.8 Billion | -12.15 Billion | 374.86 Million | -4.96 Million | 173.23 Million |
| Financing Cash Flow | -29.24 Billion | 13.11 Billion | -5.02 Billion | -16.46 Billion | -18.81 Billion | -13.26 Billion |
| Debt repayment | -21.26 Billion | -162.68 Billion | -148.6 Billion | -96.84 Billion | -112.97 Billion | -161.54 Billion |
| Dividends payments | -7.74 Billion | -7.74 Billion | -7.91 Billion | -7.91 Billion | -7.91 Billion | -7.91 Billion |
| Common Stock Repurchased | - | - | -6.74 Billion | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -229.99 Million | 183.54 Billion | 158.23 Billion | 88.29 Billion | 102.07 Billion | 156.2 Billion |
| Accounts receivables | -1.83 Billion | -21.95 Billion | 2.47 Billion | -863.39 Million | -3.66 Billion | 11.9 Billion |
| Accounts payables | 3.53 Billion | 2.72 Billion | -2.07 Billion | 4.85 Billion | -340.87 Million | -180.97 Million |
| Inventory | -1.28 Billion | -1.05 Billion | -4.51 Billion | -999.72 Million | -1.14 Billion | -2.49 Billion |
| Other working capital | -1.7 Billion | -2.1 Billion | 452.04 Million | -4.58 Billion | -7.97 Billion | 9.76 Billion |
| Cash at beginning of period | 3.91 Billion | 4.92 Billion | 2.59 Billion | 9.86 Billion | 12.77 Billion | 300.58 Million |
| Cash at end of period | 20.22 Billion | 3.91 Billion | 4.92 Billion | 2.59 Billion | 9.86 Billion | 12.77 Billion |
| Capital Expenditure | -8.26 Billion | -8.29 Billion | -19.39 Billion | -16.23 Billion | -8.35 Billion | -10.56 Billion |
| Effect of forex changes on cash | - | - | - | - | -10.00 | - |
| Net cash flow / Change in cash | 16.3 Billion | -1 Billion | 2.33 Billion | -7.26 Billion | -2.91 Billion | 12.47 Billion |
| Free Cash Flow | 29.23 Billion | 5.83 Billion | 10.76 Billion | 30.51 Billion | 15.91 Billion | 25.56 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 6.65 Billion | 5.13 Billion | 28.14 Billion | 10.26 Billion | 4.55 Billion | 5.66 Billion |
| Depreciation & Amortization | 3.91 Billion | 3.91 Billion | 15.5 Billion | 3.91 Billion | 3.91 Billion | 3.84 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 120.69 Million | -3 Billion | -1.28 Billion | 1.11 Billion | -13.68 Billion | -3.52 Billion |
| Other non-cash items | -971.86 Million | 11.96 Billion | -4.86 Billion | -4.23 Billion | 584.79 Million | 64.25 Million |
| Investing Cash Flow | -655.44 Million | -2.65 Billion | 8.03 Billion | -2.44 Billion | -2.95 Billion | -4.97 Billion |
| Investments in PPE | -1.48 Billion | -1.57 Billion | -8.26 Billion | -2.66 Billion | -2.9 Billion | -1.09 Billion |
| Acquisitions | - | 4.9 Million | 3.69 Million | 3.69 Million | - | -22 Million |
| Investment purchases | -2.01 Billion | -8 Billion | -21.2 Billion | -13.2 Billion | - | -3 Billion |
| Sales/Maturities of investments | 3.5 Billion | 8.01 Billion | 38.23 Billion | 13.2 Billion | - | 22 Million |
| Other Investing Activities | 827.39 Million | -1.1 Billion | -736.19 Million | 214.25 Million | -53.58 Million | -874.83 Million |
| Financing Cash Flow | -7.84 Billion | -105.17 Million | -29.24 Billion | -6.09 Billion | -113.99 Million | -24.47 Billion |
| Debt repayment | -30.1 Billion | -84 Million | -21.26 Billion | -84 Million | -6.08 Billion | -30.38 Billion |
| Dividends payments | -7.74 Billion | - | -7.74 Billion | - | - | -7.74 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 30 Billion | - | -229.99 Million | -6.01 Billion | 5.97 Billion | 13.65 Billion |
| Accounts receivables | 104.33 Million | -1.86 Billion | -1.83 Billion | -1.59 Billion | -15.23 Billion | -2.61 Billion |
| Accounts payables | -944.24 Million | 1.87 Billion | 3.53 Billion | 4.2 Billion | 1.97 Billion | -1.18 Billion |
| Inventory | -405.88 Million | -1.45 Billion | -1.28 Billion | -743.89 Million | 1.04 Billion | 533.33 Million |
| Other working capital | 422.24 Million | -1.55 Billion | -1.7 Billion | -757.6 Million | -1.47 Billion | -258.63 Million |
| Cash at beginning of period | 26.2 Billion | 20.22 Billion | 3.91 Billion | 17.7 Billion | 25.4 Billion | 48.79 Billion |
| Cash at end of period | 27.42 Billion | 26.2 Billion | 20.22 Billion | 20.22 Billion | 17.7 Billion | 25.4 Billion |
| Capital Expenditure | -1.48 Billion | -1.57 Billion | -8.26 Billion | -2.66 Billion | -2.9 Billion | -1.09 Billion |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.22 Billion | 5.97 Billion | 16.3 Billion | 2.51 Billion | -7.7 Billion | -23.39 Billion |
| Free Cash Flow | 8.24 Billion | 7.16 Billion | 29.23 Billion | 8.39 Billion | -7.53 Billion | 4.95 Billion |
300976
004100
1198
LDX
600289
301135